Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 62484-12-2 | MDL No. : | MFCD18427204 |
Formula : | C9H8N2O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | BTEAXSZDTYHOGC-UHFFFAOYSA-N |
M.W : | 192.17 | Pubchem ID : | 19604241 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 10 |
Fraction Csp3 : | 0.11 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 50.08 |
TPSA : | 75.47 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.43 cm/s |
Log Po/w (iLOGP) : | 1.79 |
Log Po/w (XLOGP3) : | 1.47 |
Log Po/w (WLOGP) : | 1.05 |
Log Po/w (MLOGP) : | 0.24 |
Log Po/w (SILICOS-IT) : | 0.93 |
Consensus Log Po/w : | 1.09 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.42 |
Solubility : | 0.73 mg/ml ; 0.0038 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.66 |
Solubility : | 0.419 mg/ml ; 0.00218 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.31 |
Solubility : | 0.943 mg/ml ; 0.00491 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.7 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
54% | With trichlorophosphate In acetonitrile for 8 h; Reflux | 7-methoxyquinazoline-2,4(lH,3H)dione (0.31 g; 1.6 mmol) was added to a solution of POC13(10 mL; 107 mmol) in 3 mL of acetonitrile and the mixture was heated to reflux for 8 h. The mixture was poured into ice water and was vigorously stirred and the resulting precipitate was filtered and dried. The precipitate was filtered through silica using dichloromethane to afford 9 as a white powder (0.201 g; 0.88 mmol; 54 percent). 1H NMR (500 MHz; DMSO) δ 8.1 (d, J=9.21 Hz, 1H, Ha4), 7.44 (dd, J=2.08, 9.26 Hz, 1H, Ha5), 7.38 (d, J=2.07 Hz, 1H, Ha7), 3.99 (s, 3H, Hbl). 13C NMR (125 MHz; DMSO) δ 166.2 (Ca6), 162.17 (Ca2), 158 (Cal), 154.9 (Ca8), 127.7 (Ca4), 122.95 (Ca5), 117.2 (Ca3), 106.5 (Ca7), 57 (Cbl). HRMS-ESI (m/z) calculated for C9H6C12N20: 227.9918 [M+H]+ ; found: 227.9935 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
0.64 g | Reflux | <Step 2> 2,4-dichloro-7-methoxyquinazoline A mixture of 7-methoxyquinazolin-2,4-diol (3 g, 15.6 mmol) prepared in Step 1 and phosphorus oxychloride (10 ml) was stirred at reflux overnight. After cooling the reaction mixture to room temperature, the same was added into ice water, and basified to pH 7-8 by using sodium bicarbonate. The aqueous layer was extracted with dichloromethane, and the organic layer was dried on anhydrous magnesium sulfate and concentrated under reduced pressure. The resulting residue was purified with silica gel column chromatography (n-hexane/ethyl acetate=10/1) to give the titled compound (0.64 g) as a white solid. 1H NMR (400 MHz, CDCl3) δ 8.12 (d, 1H), 7.37-7.20 (m, 2H), 3.99 (s, 3H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
48% | at 155℃; for 16 h; | A mixture of 2-amino-4-methoxybenzoic acid (1 g; 5.98 mmol) and urea (7.18 g; 120 mmol) was stirred at 155°C for 16 h. The reaction mixture was cooled to 100°C and then 3 mL of water was added. The mixture was cooled to room temperature and was filtered. 30 mL of 1 mol/L NaOH aqueous solution was added to dissolve the precipitate. After one hour, 4.2 mL of acetic acid was added dropwise and the resulting light brown precipitate was filtered and dried. 8 was obtained as a light brown powder (0.55 g; 2.9 mmol; 48 percent). 1H NMR (500 MHz; DMSO) δ 11.10 (brs, 1H, HNH), 10.55 (brs, 1H, HNH), 7.8 (d, J=8.63 Hz, 1H, Ha4), 6.77 (dd, J=2.44, 8.84 Hz, 1H, Ha5), 6.64 (d, J=2.43 Hz, 1H, Ha7), 3.82 (s, 3H, Hbl). 13C NMR (125 MHz; DMSO) δ 164.8 (Ca6), 162.8 (Ca2), 151 (Cal), 143.3 (Ca8), 129.3 (Ca4), 111 (Ca5), 108.2 (Ca3), 98.8 (Ca7), 56.1 (Cbl). HRMS-ESI (m/z) calculated for C9H8N203: 193.0489 [M+H]+ ; found: 193.0511 |
[ 674810-96-9 ]
4-(4-Methoxyphenyl)pyrimidin-2-ol
Similarity: 0.85
[ 179688-01-8 ]
7-(Benzyloxy)-6-methoxyquinazolin-4(3H)-one
Similarity: 0.83
[ 99844-02-7 ]
4-(4-Methoxyphenyl)pyrimidin-2-amine
Similarity: 0.72
[ 674810-96-9 ]
4-(4-Methoxyphenyl)pyrimidin-2-ol
Similarity: 0.85
[ 179688-01-8 ]
7-(Benzyloxy)-6-methoxyquinazolin-4(3H)-one
Similarity: 0.83
[ 114703-12-7 ]
7-Bromoquinazoline-2,4(1H,3H)-dione
Similarity: 0.80
[ 179688-01-8 ]
7-(Benzyloxy)-6-methoxyquinazolin-4(3H)-one
Similarity: 0.83
[ 114703-12-7 ]
7-Bromoquinazoline-2,4(1H,3H)-dione
Similarity: 0.80